Form 4 for RLAY Relay Therapeutics, Inc.
Accepted 2026-01-07 00:00:00 ET · period of report 2026-01-06 · accession 0001193125-26-006328 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-07 | 2026-01-06 | RLAY | Patel Sanjiv | Pres, CEO, Dir | S - Sale | $7.82 | -43.2K | 661.0K | -6% | -$337.6K | |
| 2026-01-07 | 2025-12-31 | RLAY | Patel Sanjiv | Pres, CEO, Dir | A - Grant | $2.99 | +994 | 704.2K | +0.1% | +$2,972 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-06 | S | D | 43,168 | $7.82 | 661,041 | D | — | — | (F4) Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 136,854 shares of RSUs on January 5, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. |
| 2 | Common | Common Stock | 2025-12-31 | A | A | 994 | $2.99 | 704,209 | D | — | — | (F2) In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on July 1, 2025. (F3) Includes 136,854 shares underlying restricted stock units ("RSUs"). |